Another selective COX-2 inhibitor, Iguratimod, has been reported to play an anti-inflammatory role against cerulein plus LPS-induced AP in mice through inhibition of the NF-κB signaling pathway and NLRP3 inflammasome activity [118]. Here, NLRP3 is linked to alkaline phosphatase measurement.